Phase 1 N=36 Cilostazol 100 mg Tablet Formulations Under Fasting Conditions
Healthy
Primary: Cmax - Maximum Observed Concentration — 536; 543 ng/mL
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 1 N=80 A Relative Bioavailability Study of 200mg/5 mL Azithromycin Oral Suspension Under Non-Fasting Conditions
Healthy
Primary: Cmax - Maximum Observed Concentration — 560.56; 562.97 ng/mL
Phase 1 N=39 Cefprozil 500 mg Tablets Under Fed Conditions
Healthy
Primary: Cmax (Maximum Observed Concentration) — 14.151; 13.672 ng/mL
Phase 1 N=26 Cefprozil for Oral Suspension 250 mg/5 mL, Non-fasting
Healthy
Primary: Cmax (Maximum Observed Concentration) — 4.367; 4.915 ng/mL
Phase 1 N=66 Clarithromycin 500 mg Extended Release Tablets Under Fasting Conditions
Healthy
Primary: Cmax - Maximum Observed Concentration — 640.08; 640.11 ng/mL
Phase 1 N=24 Clindamycin 300 mg Capsules in Healthy Subjects Under Fasting Conditions
Healthy
Primary: Bioequivalence Based on Cmax — 3008.88; 3086.02 ng/mL
Phase 1 N=26 Cefadroxil 500 mg Capsules Under Fasting Conditions
Healthy
Primary: Cmax (Maximum Observed Concentration) — 16.595; 16.744 ng/mL
Phase 1 N=23 Clarithromycin 500 mg Tablets Under Non-Fasting Conditions
Healthy
Primary: Cmax - Maximum Observed Concentration — 2440.545; 2414.955 ng/mL
Phase 1 N=92 Ursodiol 500 mg Tablets Under Fed Conditions
Healthy
Primary: Cmax - Maximum Observed Concentration - for Total Ursodiol — 6763.805; 7461.161 ng/mL
Phase 1 N=56 Clarithromycin 500 mg Tablets Under Fasting Conditions
Healthy
Primary: Cmax - Maximum Observed Concentration — 2170.964; 2214.636 ng/mL
Phase 1 N=80 Ursodiol Tablets 500 mg Under Fasting Conditions
Healthy
Primary: Cmax - Maximum Observed Concentration - for Total Ursodiol — 4946.800; 5026.891 ng/mL
Phase 1 N=80 A Relative Bioavailability Study of 200mg/5 mL Azithromycin Oral Suspension Under Fasting Conditions
Healthy
Primary: Cmax - Maximum Observed Concentration — 465.66; 449.85 ng/mL
Phase 1 N=26 Cefadroxil 500 mg Capsules in Normal Healthy Non-Smoking Male and Female Subjects.
Healthy
Primary: Cmax (Maximum Observed Concentration) — 12.024; 11.9 ng/mL
Phase 1 N=22 Clarithromycin 500 mg Extended Release Tablets Under Non-Fasting Conditions.
Healthy
Primary: Cmax - Maximum Observed Concentration — 1515.00; 1464.10 ng/mL
Phase 1 N=30 Cilostazol 50 mg Tablets Under Fasting Conditions
Healthy
Primary: Cmax - Maximum Observed Concentration — 376.46; 398.06 ng/mL